• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation with low-dose chemotherapy.

作者信息

Gross T G, Hinrichs S H, Winner J, Greiner T C, Kaufman S S, Sammut P H, Langnas A N

出版信息

Ann Oncol. 1998 Mar;9(3):339-40. doi: 10.1023/a:1008263226895.

DOI:10.1023/a:1008263226895
PMID:9602271
Abstract
摘要

相似文献

1
Treatment of post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation with low-dose chemotherapy.低剂量化疗治疗实体器官移植后移植后淋巴细胞增生性疾病（PTLD）
Ann Oncol. 1998 Mar;9(3):339-40. doi: 10.1023/a:1008263226895.
2
CHOP-21 for the treatment of post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation.CHOP-21方案用于实体器官移植后移植后淋巴细胞增殖性疾病（PTLD）的治疗。
Haematologica. 2007 Feb;92(2):273-4. doi: 10.3324/haematol.10595.
3
Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.低剂量化疗用于实体器官移植术后儿童的 Epstein-Barr 病毒阳性移植后淋巴细胞增生性疾病
J Clin Oncol. 2005 Sep 20;23(27):6481-8. doi: 10.1200/JCO.2005.08.074.
4
Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.单药利妥昔单抗治疗后对难治性和复发性移植后淋巴细胞增殖性疾病（PTLD）进行挽救性化疗。
Transplantation. 2007 Apr 15;83(7):912-8. doi: 10.1097/01.tp.0000258647.50947.78.
5
Low-dose chemotherapy and rituximab for posttransplant lymphoproliferative disease (PTLD): a Children's Oncology Group Report.低剂量化疗联合利妥昔单抗治疗移植后淋巴组织增生性疾病（PTLD）：一项儿童肿瘤协作组的报告。
Am J Transplant. 2012 Nov;12(11):3069-75. doi: 10.1111/j.1600-6143.2012.04206.x. Epub 2012 Aug 6.
6
Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen.采用剂量调整的ACVBP方案治疗移植后淋巴增殖性疾病的长期生存情况。
Br J Haematol. 2006 Sep;134(6):602-12. doi: 10.1111/j.1365-2141.2006.06228.x. Epub 2006 Aug 2.
7
Low-dose chemotherapy for children with post-transplant lymphoproliferative disease.
Recent Results Cancer Res. 2002;159:96-103. doi: 10.1007/978-3-642-56352-2_12.
8
Pediatric T-cell post-transplant lymphoproliferative disorder after solid organ transplantation.实体器官移植后小儿T细胞移植后淋巴组织增生性疾病
Pediatr Blood Cancer. 2008 Feb;50(2):415-8. doi: 10.1002/pbc.21072.
9
Post-Transplant Lymphoproliferative Disorder (PTLD) Manifesting in the Oral Cavity of a 13-Year-Old Liver Transplant Recipient (LTx).一名13岁肝移植受者口腔出现的移植后淋巴细胞增生性疾病（PTLD）
Ann Transplant. 2015 Aug 18;20:478-82. doi: 10.12659/AOT.893497.
10
A pilot study of chemoimmunotherapy (cyclophosphamide, prednisone, and rituximab) in patients with post-transplant lymphoproliferative disorder following solid organ transplantation.一项关于实体器官移植后移植后淋巴细胞增殖性疾病患者化疗免疫疗法（环磷酰胺、泼尼松和利妥昔单抗）的试点研究。
Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3945S-52S.

引用本文的文献

1
Remission of late-onset post-heart transplantation lymphoproliferative disorder following treatment with rituximab and modified mini-CHOP chemotherapy: A case report.利妥昔单抗联合改良mini-CHOP化疗治疗心脏移植术后迟发性淋巴增生性疾病缓解：一例报告
Exp Ther Med. 2016 Jul;12(1):262-266. doi: 10.3892/etm.2016.3310. Epub 2016 May 5.
2
Current developments in pediatric liver transplantation.小儿肝移植的当前进展
World J Hepatol. 2015 Jun 18;7(11):1509-20. doi: 10.4254/wjh.v7.i11.1509.
3
Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs).
用自体爱泼斯坦-巴尔病毒特异性细胞毒性T淋巴细胞（CTLs）治疗实体器官移植受者。
Blood. 2006 Nov 1;108(9):2942-9. doi: 10.1182/blood-2006-05-021782. Epub 2006 Jul 11.
4
Current status of liver transplantation.肝移植的现状
Indian J Pediatr. 2003 Sep;70(9):731-6. doi: 10.1007/BF02724316.
5
Organ transplant-related lymphoma.
Curr Treat Options Oncol. 2001 Aug;2(4):301-8. doi: 10.1007/s11864-001-0023-7.